Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents

Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites

(2014) Yao Qin et al.   JOURNAL OF DRUG TARGETING

Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response

(2012) C.-L. Chang et al.   CANCER RESEARCH

Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design

(2012) Jenny Z. Zhang et al.   CHEMISTRY-A EUROPEAN JOURNAL

The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation

(2012) J. Hu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Solid-phase synthesis of oxaliplatin–TAT peptide bioconjugates

(2012) Sergey Abramkin et al.   DALTON TRANSACTIONS

Harnessing chemoselective imine ligation for tethering bioactive molecules to platinum(iv) prodrugs

(2012) Daniel Yuan Qiang Wong et al.   DALTON TRANSACTIONS

Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells

(2012) Nora Graf et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

The secret ally: immunostimulation by anticancer drugs

(2012) Lorenzo Galluzzi et al.   NATURE REVIEWS DRUG DISCOVERY

A WKYMVm-Containing Combination Elicits Potent Anti-Tumor Activity in Heterotopic Cancer Animal Model

(2012) Sang Doo Kim et al.   PLoS One

Pt(iv) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate

(2011) Jenny Z. Zhang et al.   CHEMICAL COMMUNICATIONS

Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity

(2011) Chee Fei Chin et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

(2011) W. Joost Lesterhuis et al.   JOURNAL OF CLINICAL INVESTIGATION

Requirement of the Acquired Immune System in Successful Cancer Chemotherapy With cis-Diamminedichloroplatinum (II) in a Syngeneic Mouse Tumor Transplantation Model

(2011) Keisuke Taniguchi et al.   JOURNAL OF IMMUNOTHERAPY

Pt(IV) complexes as prodrugs for cisplatin

(2011) Yi Shi et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Real-Time Monitoring of Cisplatin-Induced Cell Death

(2011) Hamed Alborzinia et al.   PLoS One

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells

(2010) J Huang et al.   BRITISH JOURNAL OF CANCER

Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2

(2010) Thippadey Khau et al.   FASEB JOURNAL

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

(2010) Rupal Ramakrishnan et al.   JOURNAL OF CLINICAL INVESTIGATION

The mechanism of action of platinum anticancer agents—what do we really know about it?

(2009) Dan Gibson   DALTON TRANSACTIONS

Functional Expression of Formyl Peptide Receptor Family in Human NK Cells

(2009) S. D. Kim et al.   JOURNAL OF IMMUNOLOGY

Immunogenic death of colon cancer cells treated with oxaliplatin

(2009) A Tesniere et al.   ONCOGENE

Optimizing Size and Copy Number For PEG-fMLF (N-Formyl-methionyl-leucyl-phenylalanine) Nanocarrier Uptake by Macrophages

(2007) Li Wan et al.   BIOCONJUGATE CHEMISTRY

Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature

(2007) Sumitra Mukhopadhyay et al.   BIOCONJUGATE CHEMISTRY